(AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter earnings of $110.3 million. The Silver Spring, Maryland-based company said it had net income of $2.43 per share. Earnings, adjusted for stock option …
Yahoo!11mon
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Earlier, the stock hit $24.25, making today the first time since July ... United Therapeutics (NASDAQ:UTHR) was one of the worst-performing Nasdaq stocks of the day, plunging 13.03% to $46.34 after the FDA rejected the company's lung …
Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ: …
Mr. Michael Benkowitz is President, Chief Operating Officer of the Company. He joined United Therapeutics in 2011 as Executive Vice President, Organizational Development. In this role, he was responsible for most companywide …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
Biotechnology company United Therapeutics Corporation (UTHR), Tuesday, reported a narrower loss for the ... Per-share data have been adjusted to reflect a two-for-one stock split effected on September 22, 2009. Total revenue grew to …
To get more information, click here: http://zlk.9nl.com/united-therapeutics-uthr. There is no cost or obligation to you. If …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR Keywords: United Therapeutics, …